These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23098062)

  • 1. FGF23 is correlated with iron status but not with inflammation and decreases after iron supplementation: a supplementation study.
    Braithwaite V; Prentice AM; Doherty C; Prentice A
    Int J Pediatr Endocrinol; 2012 Oct; 2012(1):27. PubMed ID: 23098062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High fibroblast growth factor 23 levels are associated with decreased ferritin levels and increased intravenous iron doses in hemodialysis patients.
    Honda H; Michihata T; Shishido K; Takahashi K; Takahashi G; Hosaka N; Ikeda M; Sanada D; Shibata T
    PLoS One; 2017; 12(5):e0176984. PubMed ID: 28475601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron status and fibroblast growth factor-23 in Gambian children.
    Braithwaite V; Jarjou LM; Goldberg GR; Prentice A
    Bone; 2012 Jun; 50(6):1351-6. PubMed ID: 22465847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of maternal iron deficiency on infant fibroblast growth factor-23 and mineral metabolism.
    Braithwaite VS; Prentice A; Darboe MK; Prentice AM; Moore SE
    Bone; 2016 Feb; 83():1-8. PubMed ID: 26453792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of intact and C-terminal fibroblast growth factor 23 in Gambian children.
    Braithwaite V; Jones KS; Assar S; Schoenmakers I; Prentice A
    Endocr Connect; 2014; 3(1):1-10. PubMed ID: 24258305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron status biomarkers and C-reactive protein in children aged 19 to 72 months in Chile.
    Brito A; Hertrampf E; Olivares M
    Food Nutr Bull; 2013 Mar; 34(1):14-20. PubMed ID: 23767277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malaria causes long-term effects on markers of iron status in children: a critical assessment of existing clinical and epidemiological tools.
    Castberg FC; Sarbah EW; Koram KA; Opoku N; Ofori MF; Styrishave B; Hviid L; Kurtzhals JAL
    Malar J; 2018 Dec; 17(1):464. PubMed ID: 30537973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C; Ljunggren Ö; Nilsson-Ehle H; Karlsson MK; Herlitz H; Lorentzon M; Ohlsson C; Mellström D
    Bone; 2017 May; 98():1-8. PubMed ID: 28212898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for misclassification of micronutrient status in children participating in a Head Start program.
    Droke EA; Kennedy TS; Hubbs-Tait L
    J Am Diet Assoc; 2006 Mar; 106(3):376-82. PubMed ID: 16503227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma fibroblast growth factor 23 concentration and iron status. Does the relationship exist in the elderly population?
    Bożentowicz-Wikarek M; Kocełak P; Owczarek A; Olszanecka-Glinianowicz M; Mossakowska M; Skalska A; Więcek A; Chudek J
    Clin Biochem; 2015 Apr; 48(6):431-6. PubMed ID: 25583093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency, elevated erythropoietin, fibroblast growth factor 23, and mortality in the general population of the Netherlands: A cohort study.
    Eisenga MF; De Jong MA; Van der Meer P; Leaf DE; Huls G; Nolte IM; Gaillard CAJM; Bakker SJL; De Borst MH
    PLoS Med; 2019 Jun; 16(6):e1002818. PubMed ID: 31170159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria early in the first pregnancy: Potential impact of iron status.
    Diallo S; Roberts SA; Gies S; Rouamba T; Swinkels DW; Geurts-Moespot AJ; Ouedraogo S; Ouedraogo GA; Tinto H; Brabin BJ
    Clin Nutr; 2020 Jan; 39(1):204-214. PubMed ID: 30737046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Iron Replacement Normalizes Fibroblast Growth Factor 23 in Iron-Deficient Patients With Autosomal Dominant Hypophosphatemic Rickets.
    Imel EA; Liu Z; Coffman M; Acton D; Mehta R; Econs MJ
    J Bone Miner Res; 2020 Feb; 35(2):231-238. PubMed ID: 31652009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Administration of Ferric Citrate Hydrate Decreases Circulating FGF23 Levels Independently of Serum Phosphate Levels in Hemodialysis Patients with Iron Deficiency.
    Iguchi A; Kazama JJ; Yamamoto S; Yoshita K; Watanabe Y; Iino N; Narita I
    Nephron; 2015; 131(3):161-6. PubMed ID: 26551233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percentage of hypochromic red blood cells as predictor of erythropoietic and iron response after i.v. iron supplementation in maintenance haemodialysis patients.
    Braun J; Lindner K; Schreiber M; Heidler RA; Hörl WH
    Nephrol Dial Transplant; 1997 Jun; 12(6):1173-81. PubMed ID: 9198047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations Between Intravenous Iron, Inflammation and FGF23 in Non-Dialysis Patients with Chronic Kidney Disease Stages 3-5.
    Muras-Szwedziak K; Nowicki M
    Kidney Blood Press Res; 2018; 43(1):143-151. PubMed ID: 29444509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency.
    Iguchi A; Yamamoto S; Yamazaki M; Tasaki K; Suzuki Y; Kazama JJ; Narita I
    Clin Exp Nephrol; 2018 Aug; 22(4):789-796. PubMed ID: 29181658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of long-term calcium supplementation on indices of iron, zinc and magnesium status in lactating Gambian women.
    Yan L; Prentice A; Dibba B; Jarjou LM; Stirling DM; Fairweather-Tait S
    Br J Nutr; 1996 Dec; 76(6):821-31. PubMed ID: 9014651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex and Iron Modify Fibroblast Growth Factor 23 Concentration in 1-Year-Old Children.
    Holmlund-Suila E; Enlund-Cerullo M; Valkama S; Hauta-Alus H; Rosendahl J; Helve O; Hytinantti T; Viljakainen H; Andersson S; Mäkitie O
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4526-4533. PubMed ID: 29029193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans.
    Imel EA; Peacock M; Gray AK; Padgett LR; Hui SL; Econs MJ
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3541-9. PubMed ID: 21880793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.